Search

Displaying results 8651 - 8660 of 10000 in total
  1. Drug

    Talviraline

    go.drugbank.com/drugs/DB07885
    Investigational

    Talviraline has been used in trials studying the treatment of HIV Infections.

  2. Drug

    Emivirine

    go.drugbank.com/drugs/DB08188
    Investigational

    Emivirine has been used in trials studying the treatment of HIV Infections.

  3. Drug

    Ribose

    go.drugbank.com/drugs/DB15073
    Investigational

    Ribose is under investigation in clinical trial NCT01727479 (Ribose and Sport Performance).

  4. Drug

    Xanthohumol

    go.drugbank.com/drugs/DB15359
    Investigational

    Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome).

  5. Drug

    Phloretin

    go.drugbank.com/drugs/DB07810
    Experimental

    Phloretin is a natural dihydrochalcone found in apples and many other fruits.

  6. Drug

    Pyridoxamine

    go.drugbank.com/drugs/DB11673
    Investigational

    Pyridoxamine has been used in trials studying the treatment of Kidney Stones.

    Categories: Vitamin B Complex
  7. Drug

    Elsulfavirine

    go.drugbank.com/drugs/DB14929
    Investigational

    Elsulfavirine is under investigation in clinical trial NCT03706898 (Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food

  8. Drug

    Risovalisib

    go.drugbank.com/drugs/DB21474
    Investigational

    Risovalisib is under investigation in clinical trial NCT05043922 (A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma).

  9. Drug

    COVID-19 convalescent plasma

    go.drugbank.com/drugs/DB15692
    Investigational

    [L14333] This investigational COVID-19 treatment is currently available through three main pathways: use in registered clinical trials, use through the expanded access COVID-19 protocol (21 CFR 312.305 … clinical trial results for the safety or efficacy of COVID-19 convalescent plasma, early results from 5000 patients under the FDA expanded access program suggest that convalescent plasma transfusion in

  10. Drug

    Arsthinol

    go.drugbank.com/drugs/DB08928
    Experimental

    Arsthinol (INN) is an antiprotozoal agent that was first synthesized by Ernst A.H. Friedheim in 1949 via the complexing of acetarsol with 2,3-dimercaptopropanol. … Considered well tolerated when compared to other related trivalent organoarsenicals, arsthinol has even undergone recent studies as a potential anticancer agent.